Alzheimer's risk linked to B vitamins

B vitamins play a key role moderating the risk of Alzheimer's disease, research has shown.

A seven-year study from researchers at the Karolinska Institute in Sweden showed people with elevated vitamin B12 were at reduced risk of Alzheimer’s.

Researchers believe the study reinforces the link between B vitamins and the condition. The Alzheimer’s Research Trust called for a large-scale trial to conclusively prove the association.

Many previous studies had linked the amino acid homocysteine, which is associated with vitamin B12, to the development of cardio/cerebrovascular diseases.

To examine whether there was also a link with Alzheimer’s, researchers analysed blood samples of 271 Finnish people aged 65-79 without dementia.

Samples were tested for homocysteine and the active element of vitamin B12, holotranscobalamin.

Researchers saw that elevated homocysteine levels increased the risk of Alzheimer’s. But they also found a rise in holotranscobalamin levels reduced risk.

Researchers said further work may allow vitamin B12 to be used as a marker to identify patients at increased risk.

Professor Helga Refsum of the Alzheimer’s Research Trust said: ‘This study adds further evidence that low vitamin B12 status is associated with Alzheimer's, and it is probably the first to link the active component of the vitamin to the incidence of dementia.’
 
Rebecca Wood, chief executive of the Alzheimer’s Research Trust, said: ‘Discussion continues around how much promise B vitamins hold in protecting us from dementia, a debate that can only be put to bed by a comprehensive large scale trial.’

But she warned against patients ‘stocking the cupboard’ with vitamin B supplements, saying it was too early to be sure of the benefits.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Free coronavirus news and resources on GPonline, MIMS and MIMS Learning

Free coronavirus news and resources on GPonline, MIMS and MIMS Learning

As the coronavirus crisis continues, we at Haymarket are constantly seeking new ways...

Quarter of GPs self isolating for coronavirus as Hancock promises 100,000 tests a day

Quarter of GPs self isolating for coronavirus as Hancock promises 100,000 tests a day

Around one in four GPs are self isolating - many of them unnecessarily - as frontline...

Cashflow fears for locums as government relaxes 10-week pension rule

Cashflow fears for locums as government relaxes 10-week pension rule

Locums will have longer to declare pensionable income under plans to relax a 10-week...

More than 6,000 GPs in second wave of doctors given temporary GMC registration

More than 6,000 GPs in second wave of doctors given temporary GMC registration

More than 6,000 GPs who have retired or no longer hold a licence to practise are...

Updated PHE advice on PPE backs eye protection for GPs

Updated PHE advice on PPE backs eye protection for GPs

GPs should wear eye protection in addition to a mask, gloves and apron when providing...

Repurpose industry now to tackle PPE shortage, says doctors' union

Repurpose industry now to tackle PPE shortage, says doctors' union

UK industry should be 'immediately repurposed' to produce personal protective equipment...